0000950170-22-018299.txt : 20220909 0000950170-22-018299.hdr.sgml : 20220909 20220909162051 ACCESSION NUMBER: 0000950170-22-018299 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220909 DATE AS OF CHANGE: 20220909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: F-star Therapeutics, Inc. CENTRAL INDEX KEY: 0001566373 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522386345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37718 FILM NUMBER: 221236434 BUSINESS ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 44 1223 497400 MAIL ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: Spring Bank Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130108 10-Q/A 1 fstx-20220630.htm 10-Q/A 10-Q/A
Q20001566373true--12-3100015663732022-06-3000015663732022-01-012022-06-30xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q/A

AMENDMENT NO. 1

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2022

or

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from

 

to

 

 

Commission File Number: 001-37718

 

F-STAR THERAPEUTICS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

52-2386345

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

Eddeva B920 Babraham Research Campus

Cambridge, United Kingdom

CB22 3AT

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: +44-1223-497400

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading

Symbol

 

Name of each exchange
on which registered

 

Common Stock, $0.0001 par value per share

FSTX

The Nasdaq Stock Market

(Nasdaq Capital Market)

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ NO ☐

 

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

☐

Accelerated filer

☐

 

 

 

 

Non-accelerated filer

☒

Smaller reporting company

☒

 

 

 

 

 

 

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☒

The number of shares of Registrant’s Common Stock outstanding as of June 30, 2022 was 21,584,723.

 

 

 

 

 

 

EXPLANATORY NOTE

 

F-star Therapeutics, Inc. (“F-star”, “our” or “we”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) to its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022 (the “Original Form 10-Q”), which was filed with the Securities and Exchange Commission on August 11, 2022. This Amendment replaces in its entirety Part I, Item 4 “Controls and Procedures” (“Item 4”) of the Original Form 10-Q, which inadvertently did not include the conclusion by our Chief Executive Officer and Chief Financial Officer of the effectiveness of our disclosure controls and procedures, as required by Item 307 of Regulation S-K.

 

The new Item 4 provided by this Amendment includes a statement regarding the conclusion of our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures were effective as of June 30, 2022.

 

This Amendment does not amend the Original Form 10-Q in any other way. Specifically, it does not update the Original Form 10-Q to reflect events occurring after August 11, 2022.

 

The complete text of Item 4, including the revised language referenced above, is provided below.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As of June 30, 2022, our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based on their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that such disclosure controls and procedures were effective as of June 30, 2022.

Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended June 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

1

 

EXHIBIT INDEX

 

Item 601 of Regulation S-K requires the exhibits listed below.

 

Exhibit

Number

 

Description

 

31.1

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

31.2

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

2

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

F-star Therapeutics, Inc.

 

 

 

 

Date: September 9, 2022

 

By:

/s/ Eliot R. Forster

 

 

 

 

Eliot R. Forster, Ph.D.

 

 

 

President and Chief Executive Officer

 

3

 EX-31.1 2 fstx-ex31_1.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Eliot R. Forster, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q/A of F-star Therapeutics, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 9, 2022

 

By:

/s/ Eliot R. Forster

 

 

 

Eliot R. Forster, Ph.D.

 

 

 

President and Chief Executive Officer

 

 EX-31.2 3 fstx-ex31_2.htm EX-31.2 EX-31.2

 

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Darlene Deptula-Hicks, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q/A of F-star Therapeutics, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
1.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
2.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
3.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
4.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
1.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
2.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 9, 2022

 

By:

/s/ Darlene Deptula-Hicks

 

 

 

Darlene Deptula-Hicks

 

 

 

Chief Financial Officer

 

 

 EX-101.PRE 4 fstx-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 5 fstx-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 fstx-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, City or Town Entity Address, City or Town Entity Ex Transition Period Entity Ex Transition Period Amendment Flag Amendment Flag Document Quarterly Report Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Small Business Entity Small Business City Area Code City Area Code Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Fiscal Period Focus Document Fiscal Period Focus Entity File Number Entity File Number Current Fiscal Year End Date Current Fiscal Year End Date Entity Address, Address Line One Entity Address, Address Line One Entity Filer Category Entity Filer Category Entity Current Reporting Status Entity Tax Identification Number Entity Tax Identification Number Entity Emerging Growth Company Entity Emerging Growth Company Document Transition Report Document Transition Report Amendment Description Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Registrant Name Entity Registrant Name Title of 12(b) Security Title of 12(b) Security Document Type Document Type Entity Shell Company Entity Shell Company Security Exchange Name Security Exchange Name Entity Address, Country Entity Address, Country Entity Central Index Key Entity Central Index Key Accounting Policies [Abstract] Entity Interactive Data Current Entity Interactive Data Current Local Phone Number Local Phone Number Document Fiscal Year Focus Document Fiscal Year Focus Cover [Abstract] Trading Symbol Trading Symbol XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover Page
 6 Months Ended
Jun. 30, 2022
shares
Cover [Abstract]  
Document Type 10-Q/A
Amendment Flag true
Amendment Description F-star Therapeutics, Inc. (“F-star”, “our” or “we”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) to its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022 (the “Original Form 10-Q”), which was filed with the Securities and Exchange Commission on August 11, 2022. This Amendment replaces in its entirety Part I, Item 4 “Controls and Procedures” (“Item 4”) of the Original Form 10-Q, which inadvertently did not include the conclusion by our Chief Executive Officer and Chief Financial Officer of the effectiveness of our disclosure controls and procedures, as required by Item 307 of Regulation S-K. The new Item 4 provided by this Amendment includes a statement regarding the conclusion of our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures were effective as of June 30, 2022. This Amendment does not amend the Original Form 10-Q in any other way. Specifically, it does not update the Original Form 10-Q to reflect events occurring after August 11, 2022.
Document Period End Date Jun. 30, 2022
Document Fiscal Year Focus 2022
Document Fiscal Period Focus Q2
Trading Symbol FSTX
Title of 12(b) Security Common Stock, $0.0001 par value per
Security Exchange Name NASDAQ
Entity Registrant Name F-STAR THERAPEUTICS, INC.
Entity Central Index Key 0001566373
Current Fiscal Year End Date --12-31
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company false
Entity Shell Company false
Document Quarterly Report true
Document Transition Report false
Entity File Number 001-37718
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 52-2386345
Entity Address, Address Line One Eddeva B920 Babraham Research Campus
Entity Address, City or Town Cambridge
Entity Address, Postal Zip Code CB22 3AT
Entity Address, Country GB
City Area Code 44
Local Phone Number 1223-497400
Entity Common Stock, Shares Outstanding 21,584,723
XML 8 fstx-20220630_htm.xml IDEA: XBRL DOCUMENT 0001566373 2022-06-30 0001566373 2022-01-01 2022-06-30 shares Q2 0001566373 true --12-31 10-Q/A true 2022-06-30 2022 false 001-37718 F-STAR THERAPEUTICS, INC. DE 52-2386345 Eddeva B920 Babraham Research Campus Cambridge GB CB22 3AT 44 1223-497400 Common Stock, $0.0001 par value per FSTX NASDAQ Yes Yes Non-accelerated Filer true false false 21584723 F-star Therapeutics, Inc. (“F-star”, “our” or “we”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) to its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022 (the “Original Form 10-Q”), which was filed with the Securities and Exchange Commission on August 11, 2022. This Amendment replaces in its entirety Part I, Item 4 “Controls and Procedures” (“Item 4”) of the Original Form 10-Q, which inadvertently did not include the conclusion by our Chief Executive Officer and Chief Financial Officer of the effectiveness of our disclosure controls and procedures, as required by Item 307 of Regulation S-K. The new Item 4 provided by this Amendment includes a statement regarding the conclusion of our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures were effective as of June 30, 2022. This Amendment does not amend the Original Form 10-Q in any other way. Specifically, it does not update the Original Form 10-Q to reflect events occurring after August 11, 2022. EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 2 30 1 false 0 0 false 1 false false R1.htm 100000 - Document - Cover Page Sheet http://www.f-star.com/20220630/taxonomy/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports fstx-20220630.htm fstx-20220630.xsd fstx-20220630_lab.xml fstx-20220630_pre.xml fstx-ex31_1.htm fstx-ex31_2.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "fstx-20220630.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 2, "dts": { "inline": { "local": [ "fstx-20220630.htm" ] }, "labelLink": { "local": [ "fstx-20220630_lab.xml" ] }, "presentationLink": { "local": [ "fstx-20220630_pre.xml" ] }, "schema": { "local": [ "fstx-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 32, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 30, "memberCustom": 0, "memberStandard": 0, "nsprefix": "fstx", "nsuri": "http://www.f-star.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "fstx-20220630.htm", "contextRef": "C_1fef85f0-b5f7-45a8-a459-6bbd6cc633f7", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Cover Page", "role": "http://www.f-star.com/20220630/taxonomy/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "fstx-20220630.htm", "contextRef": "C_1fef85f0-b5f7-45a8-a459-6bbd6cc633f7", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.f-star.com/20220630/taxonomy/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" } }, "unitCount": 1 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r4": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r5": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r6": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 15 0000950170-22-018299-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-22-018299-xbrl.zip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end